SCT | Secretin | Predicted secreted proteins
| | | | | Group enriched |
SI | Sucrase-isomaltase (alpha-glucosidase) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SLC10A2 | Solute carrier family 10 (sodium/bile acid cotransporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC15A1 | Solute carrier family 15 (oligopeptide transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC28A1 | Solute carrier family 28 (concentrative nucleoside transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC2A7 | Solute carrier family 2 (facilitated glucose transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC34A3 | Solute carrier family 34 (type II sodium/phosphate contransporter), member 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC35G1 | Solute carrier family 35, member G1 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC39A4 | Solute carrier family 39 (zinc transporter), member 4 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
SLC52A1 | Solute carrier family 52 (riboflavin transporter), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A1 | Solute carrier family 5 (sodium/glucose cotransporter), member 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A11 | Solute carrier family 5 (sodium/inositol cotransporter), member 11 | Predicted membrane proteins
| | | | | Group enriched |
SLC5A12 | Solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A4 | Solute carrier family 5 (glucose activated ion channel), member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC5A9 | Solute carrier family 5 (sodium/sugar cotransporter), member 9 | Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A19 | Solute carrier family 6 (neutral amino acid transporter), member 19 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC6A4 | Solute carrier family 6 (neurotransmitter transporter), member 4 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC7A9 | Solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SMLR1 | Small leucine-rich protein 1 | Predicted membrane proteins
| | | | | Group enriched |
SOAT2 | Sterol O-acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
SPINK4 | Serine peptidase inhibitor, Kazal type 4 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
SULT1E1 | Sulfotransferase family 1E, estrogen-preferring, member 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Group enriched |
TBX10 | T-box 10 | Predicted secreted proteins Transcription factors
| | | | | Group enriched |
TM4SF20 | Transmembrane 4 L six family member 20 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
TM4SF4 | Transmembrane 4 L six family member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
TM6SF2 | Transmembrane 6 superfamily member 2 | Predicted membrane proteins
| | | | | Group enriched |
TMEM236 | Transmembrane protein 236 | Predicted membrane proteins
| | | | | Group enriched |
TMEM253 | Transmembrane protein 253 | Predicted membrane proteins
| | | | | Group enriched |
TMEM82 | Transmembrane protein 82 | Predicted membrane proteins
| | | | | Group enriched |
TMIGD1 | Transmembrane and immunoglobulin domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
TPSG1 | Tryptase gamma 1 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
TREH | Trehalase (brush-border membrane glycoprotein) | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
TRPM5 | Transient receptor potential cation channel, subfamily M, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
TRPM6 | Transient receptor potential cation channel, subfamily M, member 6 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
UGT1A5 | UDP glucuronosyltransferase 1 family, polypeptide A5 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
UGT1A8 | UDP glucuronosyltransferase 1 family, polypeptide A8 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
UGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 | Enzymes Predicted membrane proteins
| | | | | Group enriched |
URAD | Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
VIL1 | Villin 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
VNN1 | Vanin 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
XDH | Xanthine dehydrogenase | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
XPNPEP2 | X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ADH1C | Alcohol dehydrogenase 1C (class I), gamma polypeptide | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ARL14 | ADP-ribosylation factor-like 14 | Predicted intracellular proteins
| | | | | Group enriched |
BCL2L15 | BCL2-like 15 | Predicted intracellular proteins
| | | | | Group enriched |
CAPN13 | Calpain 13 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
CASP16 | Caspase 16, apoptosis-related cysteine peptidase (putative) | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
CCR9 | Chemokine (C-C motif) receptor 9 | CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |